159 related articles for article (PubMed ID: 10596031)
1. Clinical experience with Filgrastim in AIDS.
Kuritzkes DR
J Hematother Stem Cell Res; 1999; 8 Suppl 1():S17-9. PubMed ID: 10596031
[TBL] [Abstract][Full Text] [Related]
2. Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: results of a randomized, multicenter, controlled trial. G-CSF 930101 Study Group.
Kuritzkes DR; Parenti D; Ward DJ; Rachlis A; Wong RJ; Mallon KP; Rich WJ; Jacobson MA
AIDS; 1998 Jan; 12(1):65-74. PubMed ID: 9456256
[TBL] [Abstract][Full Text] [Related]
3. Prevention of bacterial infections in patients with advanced HIV infection.
Mitsuyasu R
AIDS; 1999; 13 Suppl 2():S19-23. PubMed ID: 10596677
[TBL] [Abstract][Full Text] [Related]
4. Biopharmaceutical drug development: Filgrastim (r-metHuG-CSF) use in patients with HIV infection.
Foote M; Welch W
J Hematother Stem Cell Res; 1999; 8 Suppl 1():S3-8. PubMed ID: 10596029
[TBL] [Abstract][Full Text] [Related]
5. The use of Filgrastim in AIDS-related neutropenia.
Welch W; Foote M
J Hematother Stem Cell Res; 1999; 8 Suppl 1():S9-16. PubMed ID: 10596030
[TBL] [Abstract][Full Text] [Related]
6. Filgrastim treatment of HIV-infected patients improves neutrophil function.
Pitrak DL
AIDS; 1999; 13 Suppl 2():S25-30. PubMed ID: 10596678
[TBL] [Abstract][Full Text] [Related]
7. HIV disease-related neutropenia: an independent risk factor for severe infections.
Hermans P
AIDS; 1999; 13 Suppl 2():S11-7. PubMed ID: 10596676
[TBL] [Abstract][Full Text] [Related]
8. Filgrastim: new indication. AIDS-associated neutropenia: another soft indication.
Prescrire Int; 2001 Aug; 10(54):106-7. PubMed ID: 11718177
[TBL] [Abstract][Full Text] [Related]
9. Influence of filgrastim (granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitis.
Davidson M; Min YI; Holbrook JT; Van Natta M; Quinn TC; Murphy RL; Welch W; Jabs DA; Meinert CL;
J Infect Dis; 2002 Oct; 186(7):1013-8. PubMed ID: 12232843
[TBL] [Abstract][Full Text] [Related]
10. Filgrastim in patients with neutropenia: potential effects on quality of life.
Lyman GH; Kuderer NM
Drugs; 2002; 62 Suppl 1():65-78. PubMed ID: 12479595
[TBL] [Abstract][Full Text] [Related]
11. Immune reconstitution: is there a potential role for Filgrastim (r-metHuG-CSF).
Walker BD
J Hematother Stem Cell Res; 1999; 8 Suppl 1():S1-2. PubMed ID: 10596028
[No Abstract] [Full Text] [Related]
12. Treatment of HIV-related neutropenia.
Wong RJ
Am J Health Syst Pharm; 1999 Dec; 56 Suppl 5():S17-20. PubMed ID: 10613382
[TBL] [Abstract][Full Text] [Related]
13. Use of Granulocyte Colony-Stimulating Factor in a Neutropenic HIV-Infected Patient on Clozapine.
Elmore H; Lewin J; Bradley M; Sinkman A
Psychosomatics; 2016; 57(6):651-654. PubMed ID: 27720385
[No Abstract] [Full Text] [Related]
14. Mycobacterium avium complex and HIV.
Chaisson RE
J Int Assoc Physicians AIDS Care; 1995 Aug; 1(7):10-5. PubMed ID: 11362745
[TBL] [Abstract][Full Text] [Related]
15. Filgrastim to treat neutropenia and support myelosuppressive medication dosing in HIV infection. G-CSF 92105 Study Group.
Hermans P; Rozenbaum W; Jou A; Castelli F; Borleffs J; Gray S; Ward N; Gori A; De Bona A; Ferré C; Loncà M; Lang JM; Ammassari A; Clumeck N
AIDS; 1996 Dec; 10(14):1627-33. PubMed ID: 8970682
[TBL] [Abstract][Full Text] [Related]
16. Prospective and randomized comparison of early versus delayed prophylactic administration of granulocyte colony-stimulating factor (filgrastim) in children with cancer.
Rahiala J; Perkkiö M; Riikonen P
Med Pediatr Oncol; 1999 May; 32(5):326-30. PubMed ID: 10219332
[TBL] [Abstract][Full Text] [Related]
17. XM02, the first granulocyte colony-stimulating factor biosimilar, is safe and effective in reducing the duration of severe neutropenia and incidence of febrile neutropenia in patients with non-Hodgkin lymphoma receiving chemotherapy.
Engert A; Griskevicius L; Zyuzgin Y; Lubenau H; del Giglio A
Leuk Lymphoma; 2009 Mar; 50(3):374-9. PubMed ID: 19347726
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte colony-stimulating factor: its potential role in infectious disease.
Hartung T
AIDS; 1999; 13 Suppl 2():S3-9. PubMed ID: 10596675
[TBL] [Abstract][Full Text] [Related]
19. Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor.
Kuritzkes DR
Clin Infect Dis; 2000 Feb; 30(2):256-60. PubMed ID: 10671324
[TBL] [Abstract][Full Text] [Related]
20. The use of GM-CSF in AIDS.
Scadden DT
Infection; 1992; 20 Suppl 2():S103-6. PubMed ID: 1283604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
